IRS allows immediate expensing for all SMB R&D claims

bigstock Business Idea concept busines 82511486 900x600.jpg

For taxpayers, with a taxable year beginning in 2024 and ending before September 15, 2025, the IRS is granting an automatic extension of time to file superseding tax returns.

Introduction

On July 4, 2025, the One, Big, Beautiful Bill Act (OBBBA) was enacted, bringing significant changes to the treatment of research and experimental (R&E) expenditures under the U.S. Internal Revenue Code. Revenue Procedure 2025-28, released by the IRS, outlines the procedures for taxpayers to adapt to these changes, including new elections and methods of accounting for domestic and foreign R&E expenditures. A key highlight of this revenue procedure is the introduction of superseded return rules, which provide taxpayers with an automatic extension to file updated tax returns. Let’s dive into what this means and how it impacts businesses.

Superseded Return Rules: A Lifeline for 2024 Taxpayers

Section 8 of Rev. Proc. 2025-28 offers a critical relief provision for taxpayers with a taxable year beginning in 2024 and ending before September 15, 2025, where the original due date for their tax return (excluding extensions) was prior to September 15, 2025. This period covers what we’ll call the “2024 taxable year.” For these taxpayers, the IRS grants an automatic extension of time to file superseding tax and information returns that apply the provisions of this revenue procedure.

This extension is a game-changer for businesses that may have already filed their 2024 returns without accounting for the OBBBA’s new rules, which took effect for expenditures paid or incurred in taxable years beginning after December 31, 2024. The ability to file a superseded return allows taxpayers to correct their accounting methods and elections retroactively, ensuring compliance with the updated regulations without facing penalties for late filing – provided the new return is submitted within the extended timeframe.

Why This Matters

The OBBBA revamps the treatment of R&E expenditures, splitting them into domestic and foreign categories with distinct rules (click here for more details):

  • Domestic R&E Expenditures (Section 174A): Starting in 2025, these are immediately deductible, with an optional election to amortize over at least 60 months if capitalized. This contrasts with the previous Tax Cuts and Jobs Act (TCJA) rules, which required capitalization and amortization over 5 years.
  • Foreign R&E Expenditures (Section 174): These remain capitalized and amortized over 15 years, with new rules for handling disposed or abandoned property.

For the 2024 taxable year, businesses may have capitalized domestic R&E expenditures under the old TCJA Section 174 rules. The superseded return option allows them to adjust these treatments, potentially claiming immediate deductions or electing new amortization periods under Section 174A, depending on their circumstances.

How to Take Advantage

Taxpayers should review their 2024 R&E expenditures to determine if adjustments are necessary. The automatic extension means no formal request is needed to file a superseded return – just ensure it’s submitted by the extended deadline (likely tied to the September 15, 2025, cutoff, though exact dates should be confirmed with IRS guidance). This is particularly beneficial for small businesses and those with short 2025 taxable years, who also receive transition rules under Section 7.02 of the procedure.

Broader Context

The superseded return rules align with the OBBBA’s transition framework, which includes automatic changes in accounting methods and elections to handle unamortized amounts from prior years. For instance, taxpayers can elect to amortize remaining TCJA Section 174 amounts in full in 2025 or over two years, with no Section 481 adjustments required. This flexibility ensures a smooth shift to the new regime, minimizing tax disruptions.

Conclusion

The superseded return rules in Rev. Proc. 2025-28 are a thoughtful provision, giving taxpayers breathing room to align their 2024 filings with the OBBBA’s changes. For businesses with significant R&E spending, this could mean substantial tax savings or corrected compliance.

If you’ve filed your 2024 return and suspect it doesn’t reflect these new rules, now is the time to act. Consult with a tax professional to assess your eligibility and ensure your superseded return is filed correctly before the deadline.

Stay informed as more IRS guidance may follow, and consider leveraging this opportunity to optimize your R&E tax strategy moving forward!

R&D Tax Credit Eligibility AI Tool

directive for LBI taxpayers

directive for LBI taxpayers

What is the R&D Tax Credit?

The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.

directive for LBI taxpayers

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees – delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/

directive for LBI taxpayers

Upcoming Webinars

bigstock Image of two young businessmen 521093561 300x200

Upcoming Webinars

water tech

Upcoming Webinars


Choose your state

find-us-map

Congress passes tax bill to permanently restore R&D expensing and allow amendments for prior years

bigstock Smiling business people in mee 96690950 BW e1456197755817

Congress Passes Major Business Tax Reform Law

Congress has passed new legislation as part of the “One Big Beautiful Bill Act” (OBBBA) that updates the U.S. tax code. This new law makes significant changes to key business deductions. It primarily impacts how businesses deduct costs for research and development (R&D) and new equipment.

The law reverses tax policies that began in 2022. Until now, tax rules required businesses to capitalize their domestic R&D costs and spread the deductions over a five-year period. The new law permanently removes this requirement and makes other important changes for business tax planning.

Key Provisions of the New Law

This legislation includes several critical changes that will affect how companies calculate their taxable income. Here are the most important provisions that are now law:

  • Immediate Expensing for Domestic R&D is Restored: The law permanently repeals the R&D amortization rule under IRC Section 174. Businesses can now deduct 100% of their domestic research expenses in the year they occur. This change is effective for taxable years beginning after December 31, 2024.
  • Full Bonus Depreciation is Reinstated: The law reinstates 100% bonus depreciation. This allows businesses to write off the full cost of qualified property, like machinery and equipment, in the first year of service instead of depreciating the assets over time.
  • Transition Rules for Past R&D Costs are in Effect: The law provides transition relief for R&D expenses that businesses capitalized from 2022 to 2024. Taxpayers can now deduct the remaining unamortized balances over one or two years, which is much faster than the original five-year schedule.
  • Foreign R&D Treatment Remains Unchanged: The legislation did not change the tax rules for R&D conducted overseas. Businesses must continue to amortize these costs over a 15-year period.

How the New Law Impacts Business Operations

These tax code adjustments directly affect corporate finance and strategy. The ability to immediately deduct R&D and equipment costs will improve cash flow. This allows companies to reinvest more money into their operations and accelerate new projects.

As a result of this law, businesses must reassess their tax strategies. This is especially true for decisions about the timing of major investments and how they classify expenses.

Small Businesses (Average Gross Receipts ≤ $31M)

  • Option to file amended returns to fully expense R&E costs for 2022 to 2024, if your business’s average gross receipts for 2022, 2023, and 2024 is $31 million or less.
  • Option to file a superseded return to fully expense R&D costs for 2024 before your extended filing deadline (click here for more details)
  • Amended returns must be submitted within one year of enactment – by July 4, 2026.
  • Alternatively, small businesses may elect to take a catch-up deduction starting in 2025 (see below).

All Other Taxpayers (Including Large Businesses)

  • May elect to accelerate the deduction of any remaining unamortized domestic R&E costs from 2022–2024.
  • This is done via a change in accounting method using Form 3115, filed with the 2025 or 2026 return.
  • Taxpayers can choose to:
  • Deduct the full remaining amount in 2025, or
  • Spread the deduction evenly across 2025 and 2026.

Important Reminders

  • These provisions apply only to domestic R&E expenditures.
  • Foreign R&E costs remain subject to the existing 15-year amortization rule under §174(d).
  • The repeal of amortization is permanent, not subject to sunset provisions.

The Treasury and the IRS will provide further guidance on implementing these new rules. We will continue to monitor their announcements and share important updates. Please reach out to your local Swanson Reed director to further discuss your options to expense your R&E costs, including preparing amended tax returns, filing Form 3115, or modeling the cash flow impact of the acceleration options. 

R&D Tax Credit Eligibility AI Tool

directive for LBI taxpayers

directive for LBI taxpayers

What is the R&D Tax Credit?

The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.

directive for LBI taxpayers

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims.  Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour.  We are also able offer fixed fees and success fees in special circumstances.  Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/

directive for LBI taxpayers

Upcoming Webinars

 

bigstock Image of two young businessmen 521093561 300x200

Upcoming Webinars

 

water tech

Upcoming Webinars

 


Choose your state

find-us-map

Navigating the Funded Research Exclusion for R&D Tax Credits: Insights from Perficient Inc. and Grigsby Cases

business 2089530 1920

The Sec. 41(d)(4)(H) funded-research exclusion remains a complex issue for R&D tax credits, as demonstrated by two recent court cases: Perficient Inc. and Grigsby. These cases provide valuable interpretations of the rules governing funded research, emphasizing the importance of contract language and the risk standard and substantial-rights standard.


Understanding the Funded Research Exclusion

Under Regs. Sec. 1.41-4A(d), research funded by a grant, contract, or any third party, including government entities, is generally excluded from R&D tax credits. This regulation prevents double-dipping, ensuring only expenses genuinely borne by the taxpayer qualify.

Two standards are used to determine funded research:

  1. Risk Standard – Research is not funded if payment is contingent on successful results, meaning the taxpayer bears the financial risk if the research fails.
  2. Substantial-Rights Standard – Research is considered funded if the taxpayer retains no substantial rights in the research results. This means that if the taxpayer must transfer all rights to another party, the research is ineligible for the credit.

Case Analysis: Perficient Inc.

In Perficient Inc., a technology services company argued that it satisfied the risk standard because its contracts required client approval of deliverables before payment. Perficient contended that it was delivering a product, not performing research, thus bearing the financial risk.

However, the IRS argued that 22 of the sample projects constituted funded research, emphasizing that payments were tied to time-based milestones rather than project success. The IRS highlighted that merely including a rejection clause is insufficient; the contract must explicitly link payment to the research’s success.

Perficient also challenged the validity of the substantial-rights standard, arguing it was procedurally and substantively invalid under the Administrative Procedure Act (APA) and Chevron USA Inc. v. Natural Resource Defense Council, Inc. The company claimed it retained the rights to use the research, modifications, and derivatives, thereby meeting the substantial-rights standard.

The IRS countered that know-how is an incidental benefit, not a substantial right, aligning with previous rulings in Dynetics. The court’s decision in Perficient could significantly impact future interpretations of the substantial-rights standard.


Case Analysis: Grigsby

In GrigsbyCajun Industries LLC, a construction company, claimed the research credit for work performed under four sample contracts. Two contracts were capped-price agreements, and two were fixed-price contracts.

The court ruled that three of Cajun’s projects did not meet the substantial-rights standard because the contracts explicitly transferred all rights to the client. For instance, one contract defined the work as “work for hire,” transferring all intellectual property to the client.

For the fourth project, the court did not rule on the substantial-rights standard but concluded it failed the risk standard because the contract language stated payments included “full compensation for all loss, damages, or risks,” meaning Cajun did not bear financial risk.


Lessons from Preceding Case Law

Several key cases provide context for these rulings:

  • Fairchild Industries (1995) – Established that financial risk depends on who bears the cost if the project fails, not on profitability or progress payments.
  • Geosyntec Consultants (2015) – Determined that capped contracts are funded research because payments were not contingent on research success.
  • Lockheed Martin (2000) – Ruled that retaining the right to use research results is a substantial right, even without exclusivity.
  • Dynetics (2015) – Confirmed that skills gained from performing research are incidental benefits, not substantial rights.

These cases emphasize the importance of contract details, particularly regarding payment contingencies and intellectual property rights.


Key Takeaways for Taxpayers

  1. Contract Language Matters – Clearly define payment terms, inspection and acceptance clauses, and intellectual property rights. Payments tied to project milestones or success criteria support risk retention.
  2. Document Substantial Rights – Retain explicit rights to use research results, including improvements and modifications. Avoid broad clauses that transfer all intellectual property to the client.
  3. Review Preceding Case Law – Understanding rulings in FairchildGeosyntec, and Lockheed Martin helps in structuring contracts and anticipating IRS challenges.
  4. Consult with Tax Experts – Navigating the funded-research exclusion is complex. Engaging tax professionals can help optimize credit claims while ensuring compliance.

Conclusion

The funded-research exclusion remains a contentious area in R&D tax credits, with recent cases like Perficient Inc. and Grigsby illustrating the nuanced interpretations of the risk and substantial-rights standards. These decisions underscore the importance of contract language in determining credit eligibility.

As the IRS continues to scrutinize funded research claims, taxpayers must carefully structure agreements and document substantial rights. By learning from preceding case law and seeking expert guidance, businesses can better navigate this evolving landscape and maximize their R&D tax benefits.

For guidance tailored to your specific situation, speak to a Swanson Reed R&D Tax Credit expert.

IRS Releases new 6765 Form

directive-for-LBI-taxpayers-300x200

The IRS published the final Form 6765 and its instructions for the tax year 2024 on February 10, 2025. This form is used to claim the credit for increasing research activities. The IRS is seeking feedback on the form and instructions until June 30, 2025, to ensure that the instructions for tax year 2025 (processing year 2026) are clear and up to date.

The IRS had previously released a draft version, requesting feedback from external stakeholders and taxpayers. The new draft version has taken this feedback into account, alleviating some of the burden on the taxpayers who need to prepare this form. Their main goal is to provide taxpayers with a consistent and predefined format and improve the information received for tax administration.

The new version includes the following changes:

  • Optional reporting of Section G
  • Reduced scope of Business Component Detail and other revisions

Reporting of Section G

The previous draft version introduced Section F. With the new changes, it is now labeled Section G and provides a space to report on the Business Component Detail.

The instructions will provide that Section G will be optional for:

  • Qualified Small Business (QSB) taxpayers, defined under section 41(h)(1) & (2) who check the box to claim a reduced payroll tax credit; or
  • Taxpayers with total qualified research expenditures (QREs) equal to or less than $1.5 million, determined at the control group level, and equal to or less than $50 million of gross receipts, as determined under section 448(c)(3) (without regard to subparagraph (A) thereof), claiming a research credit on an original filed return.

Reduced scope of Business Component Detail and other revisions

Based on feedback, the IRS reduced the number of business components that must be reported under Section G. Taxpayers should report 80% of total QREs in descending order by the amount of total QREs per business component, but no more than 50 business components (with special instructions for taxpayers using the ASC 730 directive who can report ASC 730 QREs as a single line item on Section G).

In addition to reducing the number of business components, the new draft also reduces the amount of related information.

The previous draft required the taxpayer to specify if a business component is new/improved, a sale/license/lease and the narrative requirement (for original returns) that describes the information sought to be discovered. Each of these requests have since been removed.

The selections for the type of business component are reduced, and the definitions for officers, controlled group reporting and business component descriptive names will be clarified in the instructions.

The IRS published the final Form 6765 and its instructions for the tax year 2024 on February 10, 2025. This form is used to claim the credit for increasing research activities. The IRS is seeking feedback on the form and instructions until June 30, 2025, to ensure that the instructions for tax year 2025 (processing year 2026) are clear and up to date.

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.